Bitcoin (btc)$86,533.00↑ 6.50%
Ethereum (eth)$2,763.26↑ 4.77%
Tether (usdt)$0.999896↑ 0.02%
BNB (bnb)$799.72↑ 3.81%
XRP (xrp)$1.50↑ 6.38%
USDC (usdc)$0.999932↑ 0.01%
Solana (sol)$118.03↑ 6.63%
TRON (trx)$0.344233↑ 0.27%
Zcash (zec)$1,472.60↓ 2.59%
Figure Heloc (figr_heloc)$1.013↑ 0.00%
Hyperliquid (hype)$93.30↓ 0.14%
Dogecoin (doge)$0.097799↑ 11.73%
Monero (xmr)$584.28↑ 4.21%
WhiteBIT Coin (wbt)$87.01↑ 4.93%
Rain (rain)$0.014018↓ 0.55%
Bitcoin (btc)$86,533.00↑ 6.50%
Ethereum (eth)$2,763.26↑ 4.77%
Tether (usdt)$0.999896↑ 0.02%
BNB (bnb)$799.72↑ 3.81%
XRP (xrp)$1.50↑ 6.38%
USDC (usdc)$0.999932↑ 0.01%
Solana (sol)$118.03↑ 6.63%
TRON (trx)$0.344233↑ 0.27%
Zcash (zec)$1,472.60↓ 2.59%
Figure Heloc (figr_heloc)$1.013↑ 0.00%
Hyperliquid (hype)$93.30↓ 0.14%
Dogecoin (doge)$0.097799↑ 11.73%
Monero (xmr)$584.28↑ 4.21%
WhiteBIT Coin (wbt)$87.01↑ 4.93%
Rain (rain)$0.014018↓ 0.55%

Precision Medicine Startup ImpriMed Spearheads AI Breakthroughs in Canine Lymphoma Treatment at Veterinary Symposium – Draper Decentralized – 4.26.24

Published April 25, 2024

ImpriMed, a leading precision medicine startup made a significant contribution to the Symposium on Artificial Intelligence in Veterinary Medicine (SAVY) hosted by Cornell University. Dr. Sungwon Lim, CEO of ImpriMed, led a session on April 20th focusing on the application of AI in individualizing drug selection for canine lymphoma treatment.